Long term, the goal of 3D bioprinting is to be able to 3D print fully functioning organs which can be used to replace the failing biological organs of humans in need of a transplant. That may still be years off, but Chicago-based biotech startup Biolife4D this week announced a major new milestone: Its ability to bioprint human cardiac tissue.
The scientific landmark followed shortly after the company opened a new research facility in Houston. It involved the printing of a human cardiac patch, containing multiple cell types which make up the human heart. It could one day be used to help treat patients who have suffered acute heart failure in order to restore lost myocardial contractility, the ability of the heart to generate force for pumping blood around the body.